Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives.

about

The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma Renal artery embolization-indications, technical approaches and outcomes.Sunitinib in kidney cancer: 10 years of experience and development.

P2860

Q26749084-6256D426-B76B-4EFF-B07D-FE6D0F51DD64 Q38299092-2721C79C-106A-48A4-A3C4-A5172D34CAB9 Q39038214-86D7A03B-FCEA-4206-A662-1CADCE72C8C6

P2860

Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives.

Item

http://www.wikidata.org/entity/Q38068585

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Neoadjuvant treatment in advan ...... ation and future perspectives.

@en

type

Item

label

Neoadjuvant treatment in advan ...... ation and future perspectives.

@en

prefLabel

Neoadjuvant treatment in advan ...... ation and future perspectives.

@en

P1476

Neoadjuvant treatment in advan ...... ation and future perspectives.

@en

P2093

Arnaud Méjean

http://www.w3.org/2001/XMLSchema#string

Laurence Albiges

http://www.w3.org/2001/XMLSchema#string

Marc-Olivier Timsit

http://www.w3.org/2001/XMLSchema#string

P2860

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses.

A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.

Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience.

Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.

Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.

Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.

Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate.

P304

1559-1569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERA.12.142

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Arnaud Méjean

Laurence Albiges

Bernard Escudier

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23253222

http://www.w3.org/2001/XMLSchema#string

Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives.

about

P2860

P2860

Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698